Israel claims a “significant advance” towards a treatment for Covid-19 after isolating a key coronavirus antibody at its main biological research laboratory, the defense minister said Monday night.
Israel is one of many countries vying to find a cure or vaccine for Covid-19, the disease caused by the new coronavirus that emerged in China in December.
The “monoclonal neutralizing antibody” developed at the Israel Biological Research Institute (IIBR) “can neutralize it [the disease-causing coronavirus] inside the bodies of the carriers, “Defense Minister Naftali Bennett said in a statement. He added that Bennett visited IIBR on Monday where he was informed” of a significant advance in the search for an antidote to the coronavirus. “
Coronavirus around the Middle East
He quoted IIBR director Shmuel Shapira as saying the antibody formula was being patented, after which an international manufacturer would be sought to mass-produce it.
IIBR has led Israeli efforts to develop a treatment and vaccine for coronavirus, including blood testing of those who recovered from Covid-19, the respiratory illness caused by the virus.
The antibodies in such samples, proteins of the immune system that are residues of the successful overcoming of the coronavirus, are widely considered to be the key to developing a possible cure.
The antibody reported to have been isolated from IIBR is monoclonal, meaning that it was derived from a single recovered cell and therefore has a potentially more potent value for producing a treatment.
Elsewhere, coronavirus treatments have been developed from antibodies that are polyclonal or derived from two or more cells of different ancestry, the journal Science Direct reported in its May issue.
Israel was one of the first countries to close its borders and impose increasingly stringent restrictions on movements to hinder the outbreak of the domestic coronavirus. It has reported 16,246 cases and 235 deaths from the disease.